Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Disease recurrence in patients undergoing mastectomy for ductal carcinoma in situ.
Journal: Breast cancer research and treatment
Published: August 23, 2024
Cost containment analysis of superparamagnetic iron oxide (SPIO) injection in patients with ductal carcinoma in situ.
Journal: Breast cancer research and treatment
Published: June 16, 2024
Superparamagnetic iron oxide (SPIO) for axillary mapping in patients with ductal carcinoma in situ undergoing mastectomy: single-institution experience.
Journal: Breast cancer research and treatment
Published: August 07, 2023
Regarding: Predicting Regional Lymph Node Recurrence in The Modern Age of Tumor-Positive Sentinel Node Melanoma.
Journal: Annals of surgical oncology
Published: February 27, 2023
Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment.
Journal: Frontiers in oncology
Published: January 24, 2020
Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging: Results From a Large Multicenter Trial.
Journal: Annals of surgery
Published: June 13, 2019
Metastatic Melanoma Patient-Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 11, 2019
MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21.
Journal: Science translational medicine
Published: October 15, 2018
BRAF and MEK inhibitor therapy eliminates Nestin-expressing melanoma cells in human tumors.
Journal: Pigment cell & melanoma research
Published: January 09, 2018
Last Updated: 09/26/2026